UK markets close in 22 minutes

Hims & Hers Health, Inc. (HIMS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
18.08-0.52 (-2.77%)
As of 11:08AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.00B
Enterprise value 3.80B
Trailing P/E N/A
Forward P/E 123.46
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.17
Price/book (mrq)11.60
Enterprise value/revenue 3.96
Enterprise value/EBITDA 1.80k

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 3102.17%
S&P500 52-week change 328.04%
52-week high 320.11
52-week low 35.65
50-day moving average 313.99
200-day moving average 39.53

Share statistics

Avg vol (3-month) 37.8M
Avg vol (10-day) 315.64M
Shares outstanding 5206.41M
Implied shares outstanding 6214.79M
Float 8185.96M
% held by insiders 111.53%
% held by institutions 163.72%
Shares short (30 Apr 2024) 418.39M
Short ratio (30 Apr 2024) 44.27
Short % of float (30 Apr 2024) 49.78%
Short % of shares outstanding (30 Apr 2024) 48.57%
Shares short (prior month 28 Mar 2024) 412.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.25%
Operating margin (ttm)3.59%

Management effectiveness

Return on assets (ttm)-0.79%
Return on equity (ttm)-0.71%

Income statement

Revenue (ttm)959.4M
Revenue per share (ttm)4.55
Quarterly revenue growth (yoy)45.80%
Gross profit (ttm)N/A
EBITDA 5.2M
Net income avi to common (ttm)-2.35M
Diluted EPS (ttm)-0.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)203.59M
Total cash per share (mrq)0.95
Total debt (mrq)11.82M
Total debt/equity (mrq)3.43%
Current ratio (mrq)2.81
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)89.84M
Levered free cash flow (ttm)60.33M